Recently studies have suggested that amyloid precursor protein (APP) plays a major role in synaptic plasticity. In Alzheimer's disease (AD), APP is abnormally accumulated in aberrant sprouting neurites in the plaque. Furthermore, APP is localized in the synaptic apparatus and, depending on the dosage, it promotes neuritic outgrowth, synaptogenesis and neuronal survival in vitro and in vivo. Therefore, we hypothesize that a mutation in the APP gene (or a related gene) represents a predisposing condition which, in combination with adjuvant factors (eg. ischemia, aging, trauma), triggers the development of the disease. Ischemia, aging and trauma are conditions known to be associated with synaptic loss. If APP is involved in mechanisms of synaptic repair and plasticity, altered APP might lead to an abnormal reparative response and accentuation of synaptic damage. For the present project, we propose to analyze the patterns of synaptogenesis and sprouting in the brains of transgenic (tg) mice into which the human APP gene has been introduced, and that later in life received a nervous system injury (ischemia, denervation). In order to analyze the effect of these conditions on the synaptic organization of the brain, sections double-immunolabeled for APP/synaptophysin/GAP-43 will be studied with the aid of laser scanning confocal microscopy and computer aided image analysis. The following lines of mice will be analyzed at different ages: a) tg with neuron specific enolase (NSE) promoter-APP751 construct (with no mutation), b) tg with NSE-APP751 construct (with Hardy's mutation in 717), c) tg with NSE-APP695 (no mutation), d) tg with NSE-APP695(with G->A mutation), and e) corresponding non-transgenic (non-tg) controls. Groups of tg and non-tg animals will receive either entorhinal cortex lesion, global ischemia, or kindling. The information derived form this study will provide important data as to the role of APP in plasticity and could help to understand the mechanisms of synaptic pathology in AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005131-12
Application #
3726247
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Brenowitz, Willa D; Han, Fang; Kukull, Walter A et al. (2018) Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiol Aging 62:64-71
Blue, Elizabeth E; Bis, Joshua C; Dorschner, Michael O et al. (2018) Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project. Dement Geriatr Cogn Disord 45:1-17
Gallagher, Damien; Kiss, Alex; Lanctot, Krista L et al. (2018) Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors. J Clin Psychiatry 80:
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Golde, Todd E; DeKosky, Steven T; Galasko, Douglas (2018) Alzheimer's disease: The right drug, the right time. Science 362:1250-1251
Young, Jessica E; Fong, Lauren K; Frankowski, Harald et al. (2018) Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein. Stem Cell Reports 10:1046-1058
Reas, Emilie T; Hagler Jr, Donald J; White, Nathan S et al. (2018) Microstructural brain changes track cognitive decline in mild cognitive impairment. Neuroimage Clin 20:883-891
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Graves, Lisa V; Holden, Heather M; Van Etten, Emily J et al. (2018) New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease. J Int Neuropsychol Soc 24:833-841
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307

Showing the most recent 10 out of 914 publications